Avalo Therapeutics Inc (AVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -78,259 | -35,129 | -31,544 | -41,658 | -84,376 |
| Depreciation Amortization | 344 | 169 | 5,893 | 1,555 | 2,451 |
| Income taxes - deferred | 165 | 114 | 14 | 28 | 22 |
| Accounts receivable | N/A | N/A | N/A | 1,060 | 1,117 |
| Accounts payable and accrued liabilities | -146 | -163 | -2,436 | -487 | 796 |
| Other Working Capital | 3,841 | -126,319 | -9,240 | 4,770 | 3,839 |
| Other Operating Activity | 22,597 | 112,272 | 6,633 | 7,981 | 5,259 |
| Operating Cash Flow | $-51,458 | $-49,056 | $-30,680 | $-26,751 | $-70,892 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 25 | -95 | -113 |
| Purchase Of Investment | -113,720 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 32,000 | 0 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 356 | -158 | 0 | 0 |
| Investing Cash Flow | $-81,720 | $356 | $-133 | $-95 | $-113 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -21,244 | N/A | N/A |
| Common Stock Issued | 15,559 | 69,443 | 46,286 | -14,699 | 106,762 |
| Other Financing Activity | -972 | 106,406 | 0 | 0 | 0 |
| Financing Cash Flow | $14,587 | $175,849 | $25,042 | $-14,699 | $106,762 |
| Beginning Cash Position | 134,696 | 7,547 | 13,318 | 54,863 | 19,106 |
| End Cash Position | 16,105 | 134,696 | 7,547 | 13,318 | 54,863 |
| Net Cash Flow | $-118,591 | $127,149 | $-5,771 | $-41,545 | $35,757 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,458 | -49,056 | -30,680 | -26,751 | -70,892 |
| Capital Expenditure | N/A | N/A | N/A | -95 | -113 |
| Free Cash Flow | -51,458 | -49,056 | -30,680 | -26,846 | -71,005 |